FDA Panel Recommends Trulign Intraocular Lens

by Medscape • 2013/04/09 • 0 Comments

A US Food and Drug Administration advisory panel has voted to recommend the Trulign toric accommodating posterior chamber intraocular lens for premarket approval.
Medscape Medical News

← Age-Related Visual Impairments May Be Correctable

Long-Term Outcomes of Neoadjuvant Intra-arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma – Corrected Proof →

Post navigation